Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Open Heart|March 28, 2025
Echocardiography reporting in heart failure with preserved ejection fraction: Delphi consensus studyMaria F Paton, Carys Barton, Resham Baruah, et al.
Journal of the American College of Cardiology|April 23, 2016
Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart FailureHaqeel A Jamil, John Gierula, Maria F Paton, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 19, 2017
Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillatorMichael Drozd, John Gierula, Judith E Lowry, et al.
Echo Research and Practice|March 7, 2023
Atrial secondary mitral regurgitation: prevalence, characteristics, management, and long-term outcomesSam Straw, Ankit Gupta, Kerryanne Johnson, et al.
European Heart Journal Open|June 12, 2026
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving <i>de novo</i> and replacement pacemaker therapy for bradycardiaNurul H Abdul Samad, John Gierula, Judith E Lowry, et al.
European Journal of Nutrition|August 20, 2018
Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failureRichard M Cubbon, Judith E Lowry, Michael Drozd, et al.
JACC. Heart Failure|December 12, 2017
Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart FailureJohn Gierula, Maria F Paton, Judith E Lowry, et al.
Pacing and Clinical Electrophysiology : PACE|August 12, 2020
Long-term performance of left ventricular leads in cardiac resynchronisation therapyPeysh A Patel, Ramesh Nadarajah, Noman Ali, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 14, 2021
Impact of QRS duration on left ventricular remodelling and survival in patients with heart failureSam Straw, Melanie McGinlay, John Gierula, et al.
ESC Heart Failure|September 14, 2020
Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fractionSam Straw, Melanie McGinlay, Samuel D Relton, et al.
Pageof 5